Kronos Worldwide Inc. Overview
Kronos Worldwide is a pure-play, mid-cap producer of titanium dioxide (TiO2) pigments — the dominant white pigment used for opacity and brightness in coatings, plastics, paper laminates, inks and specialty applications. With six production plants in Germany, Belgium, Norway, Canada and the United States and a captive ilmenite mine in Norway, Kronos holds roughly 6% of global nameplate capacity and ~7% of global sales volume (FY2025). It is the largest TiO2 producer in Europe (≈15% share) and holds ≈19% of North American volume following the July 2024 buyout of the Louisiana Pigment Company joint venture. About 83% of capacity uses the higher-value chloride process. The company sells over 30 KRONOS-branded grades to ~3,000 customers in 100 countries. It is controlled by the Simmons-family Contran group through Valhi and NL Industries. Kronos is a classic cyclical: 2025 was a trough year (net loss $110.9M, 77% utilisation). In 2026 it is rebuilding volume and margin from a restructured cost base.
Company's own description (FY2025 10-K, paraphrased). Kronos describes itself as a leading global producer and marketer of value-added titanium dioxide pigments. TiO2 is a base industrial product used in a wide range of applications. Kronos, along with its distributors and agents, sells and provides technical service to about 3,000 customers in 100 countries. Most sales are made in Europe, North America and the Asia Pacific region. The company states it has produced and marketed TiO2 in North America and Europe for over 100 years, including its predecessors.
What the company does. Kronos converts titanium-bearing feedstocks into finished rutile TiO2 pigment through two routes:
Chloride process: This is a continuous process using purchased slag or natural rutile, chlorine and petroleum coke. It represents 83% of expected 2026 capacity across Leverkusen, Langerbrugge, Varennes and Lake Charles.
Sulfate process: This is a batch process using ilmenite from the company's own Norwegian mine and sulfuric acid. It represents 17% of capacity across Nordenham and Fredrikstad.
The base pigment is "finished" with proprietary surface treatments and micronising into application-specific grades.
Revenue model.
Source: FY2025 10-K.
Value-chain position. Kronos is a mid-stream chemical intermediate producer. It is backward-integrated in sulfate feedstock (Norwegian ilmenite mine, ~50 years of estimated reserves, which supplied 100% of sulfate feedstock in 2025). It is not integrated in chloride feedstock and buys from Rio Tinto Iron & Titanium (chloride slag, upgraded slag) and Iluka Resources (rutile). It sells forward to formulators (paint, masterbatch, plastics compounders, laminate paper makers, ink makers). It does not sell to end consumers.
Customer types and concentration. The customer base consists of domestic and international paint, plastics, decorative-laminate and paper manufacturers, plus ink, cosmetics and pharmaceutical formulators. No customer exceeded 10% of FY2025 net sales. The top ten customers accounted for ~35% (FY2025 10-K).
End-markets (FY2025 TiO2 sales volume, FY2025 10-K).
Independent characterisation. Kronos is a high-operating-leverage, single-commodity-chain business whose earnings are driven by four variables: TiO2 price, operating rate (fixed-cost absorption), feedstock/energy cost and EUR/USD. Its strategic distinctiveness rests on three features:
-
a large European chloride footprint that benefits disproportionately from EU anti-dumping duties on Chinese sulfate TiO2 and from Western capacity exits (Tronox Botlek, Venator UK);
-
proprietary chloride technology protected largely as trade secret;
-
ownership control by Contran, which has historically provided liquidity support (the Contran subordinated term loan) but limits free float and governance independence.
It is a price-taker in a market where China (led by LB Group) is the swing supplier.
Strategy
Stated strategic themes (FY2025 10-K and 2026 earnings commentary, paraphrased).
-
Customer intimacy and value selling. Build multi-level relationships with customers' senior decision-makers, provide technical service and co-develop grades. Focus sales on geographies and end-uses where higher prices can be realised, and continuously optimise customer and product portfolios.
-
Differentiation. Increasing focus on differentiated and specialty pigment grades; eight new grades since 2020.
-
Cost structure and operating efficiency. "Permanently" improve the cost structure through the Q4-2025 workforce reduction (~226 positions) and allied measures, enabling efficient operation at lower rates for extended periods.
-
Asset integration. Integrate Kronos Louisiana to capture process-innovation and product-quality synergies from applying Kronos chloride technology to the former JV plant.
-
Liquidity and balance-sheet stewardship. Manage inventory and production to preserve liquidity, reduce the dividend to $0.05/quarter, and complete refinancings (2024–2025).
-
"Control what we can control" (CEO Christian, Q2 2026). Execute operational, commercial and cost initiatives; pursue pricing actions and surcharges against elevated energy costs; deliver sustainable earnings improvement and stronger cash flow.
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026).
ESG commitments. Five of six plants hold ISO 50001:2018 energy-management certification, and every location has a local energy team. Water-risk management is in place, and Kronos publishes a periodic ESG report. Quantified Scope 1/2 targets were not found in the sources reviewed.
Medium-term financial targets / guidance. Kronos does not issue formal numeric guidance or medium-term financial targets. Qualitative outlook (Q2 2026): positive momentum into H2 2026; pricing actions and cost discipline expected to offset elevated energy costs. Long-term TiO2 demand growth is assumed at 2–3% per year, in line with GDP (FY2025 10-K).
Products & Services
Kronos markets over 30 TiO2 pigment grades under the KRONOS® trademark. Eight new grades have been added since the beginning of 2020 (FY2025 10-K). Kronos does not publish list prices; pricing is negotiated customer by customer, generally quarterly or semi-annually. The company does not disclose grade-level launch years in its filings. The catalogue below is organised by application family, the way Kronos organises it commercially, with grade examples from public product literature. Individual grade numbers should be confirmed against the current kronostio2.com datasheets.
TiO2 for Coatings (59% of FY2025 volume)
| Offering | Process | Description / capabilities | Target customer |
|---|---|---|---|
| KRONOS chloride rutile grades for architectural coatings (e.g., KRONOS 2300-series, 2190-type) | Chloride | High opacity, blue undertone, durability for interior/exterior paints | Decorative paint makers |
| KRONOS durable grades for industrial and automotive coatings (e.g., 2360/2310-type) | Chloride | High weather/UV resistance, gloss retention | Automotive OEM/refinish, coil, powder, industrial coatings |
| KRONOS grades for special-purpose coatings (traffic, appliance, aircraft) | Chloride/Sulfate | Tailored surface treatments for dispersibility and durability | Specialty coatings formulators |
TiO2 for Plastics (30%)
| Offering | Process | Description / capabilities | Target customer |
|---|---|---|---|
| KRONOS masterbatch grades (e.g., 2220/2450-type) | Chloride | High dispersibility at high loading; thermal stability; anti-lacing | Masterbatch producers (films, bottles, agricultural films) |
| KRONOS grades for PVC profiles (windows, siding) | Chloride | Weathering resistance, neutral undertone | Rigid PVC compounders |
| KRONOS grades for engineering plastics (PC, ABS) | Chloride | Masking of resin colour; brightness; durability | Automotive, appliance and electronics compounders |
TiO2 for Paper (8%)
| Offering | Process | Description / capabilities | Target customer |
|---|---|---|---|
| KRONOS decorative (laminate) paper grades (e.g., 2800-type) | Chloride/Sulfate | Light-fastness, opacity under melamine-resin lamination | Décor paper makers (furniture, flooring, countertops) |
| Coated board / filled paper grades | Sulfate | Whiteness, brightness, opacity | Paper and board mills |
TiO2 for Other and Specialty Applications (3%)
| Offering | Process | Description / capabilities | Target customer |
|---|---|---|---|
| Printing-ink grades | Chloride | High print quality, low abrasion, high-speed compatibility | Packaging ink makers (white inks) |
| Fibre delustering grades (anatase) | Sulfate | Opacifying and delustering for rayon and polyester | Synthetic fibre producers |
| KRONOS purified anatase (cosmetics/pharma, e.g., 1171-type) | Sulfate | Meets CTFA, USP, BP and FDA requirements | Cosmetics, toothpaste and pharmaceutical tablet-coating makers |
| Food/specialty anatase | Sulfate | High purity, warm undertone | Specialty formulators (subject to regional regulation; E171 is banned as a food additive in the EU since 2022) |
Complementary Businesses (≈10% of FY2025 net sales)
| Business | Description | Customers |
|---|---|---|
| Ilmenite ore (Norway mine) | Rock ilmenite under a government concession with unlimited term; ~50 years of reserves (internal estimate); 229 kt mined and used internally in 2025; surplus sold | Third-party sulfate TiO2 producers, including competitors |
| KRONOS ecochem® iron chemicals | Co-products of sulfate and chloride processes (e.g., iron sulfate, iron chloride solutions) | Municipal and industrial wastewater treatment, iron-pigment, cement and agricultural users |
| Specialty titanium chemicals | Side-stream products (e.g., titanium chemicals made at Langerbrugge and Varennes) | Pearlescent-pigment makers, electroceramic capacitor producers (phones and electronics), natural-gas pipeline and other specialty users |
Services
Technical and application service is bundled with product supply. It includes formulation problem-solving, grade customisation and co-development of new grades, delivered through a direct sales force and technical service group in Europe and North America. Kronos has no separately priced service or licensing offering (FY2025 10-K).
Delivery formats. Dry (bags/bulk) and slurry. Slurry facilities operate at Varennes and Lake Charles. Products ship by rail, truck and ocean carrier.
Financial Narrative
Sources and conventions.
-
FY2024–FY2025 income-statement lines are from the company's FY2025 10-K and Q4 2025 release.
-
FY2021–FY2023 lines and all balance-sheet and cash-flow lines are from S&P Global Market Intelligence standardised data (via StockAnalysis.com, updated 5 Aug 2026), which is sourced from 10-K filings.
-
S&P's standardised gross profit and operating income differ from company-reported figures because of classification (FY2024: company gross margin 359.3 vs S&P 375.3; FY2025: 213.0 vs 216.9; company income from operations FY2024 122.9 vs S&P 137.9; FY2025 -36.5 vs S&P -43.7). The S&P series is used below for five-year consistency. Company figures are cited in the commentary.
-
EBITDA uses the company definition: net income + interest expense + income taxes + depreciation and amortisation. FY2024–FY2025 are company-reported; FY2021–FY2023 are analyst-computed from S&P components.
Margins (%)
Revenue CAGR FY2021–FY2025: −1.0% per year (1,939.4 → 1,859.4). FY2024 EBITDA includes a $64.5M non-cash LPC remeasurement gain; excluding it, FY2024 EBITDA was ≈$188.4M (10.0% margin). FY2025 EBITDA includes a $4.6M earn-out remeasurement gain and is burdened by $10.3M restructuring, a $9.0M pension settlement and ≈$111M of unabsorbed fixed costs.
H1 comparison (company-reported, USD M).
Balance Sheet
Net debt here is total debt minus cash and excludes restricted cash. S&P reports net debt including restricted cash at 60.5 / 115.4 / 266.5 / 417.9 / 542.3. Company-reported total consolidated debt (excluding leases) at 31 Dec 2025 was $557.4M (FY2025 10-K).
Debt composition at 31 Dec 2025 (FY2025 10-K; Valhi FY2025 filings).
At 30 Jun 2026, total debt including leases was $588.6M and cash $26.6M (S&P Global).
Cash Flow
TTM to 30 Jun 2026: operating cash flow $86.2M, capex $46.0M, FCF $40.2M, dividends paid $23.0M (S&P Global). The TTM improvement reflects a $177M inventory release.
Ratios (analyst-computed from the tables above)
Interpretive notes: FY2023 net debt/EBITDA is not meaningful because EBITDA was negative. FY2024 net debt/EBITDA excluding the LPC gain is ≈2.2x. FY2025 net debt/EBITDA of ~34x reflects trough EBITDA. On TTM Q2-2026 EBITDA of ≈$23.3M (derived: FY2025 16.1 − H1-25 73.4 + H1-26 80.6), leverage remains above 20x. On an annualised Q2-2026 run-rate (≈$212M), it would be ≈2.6x.
Commentary on trends, inflections and drivers
FY2021–FY2022: cyclical peak. Post-COVID restocking drove revenue to $1.94bn in 2021 with an 11.6% EBITDA margin and $148M of FCF. In 2022, record pricing offset falling volumes, but inventory built by ~$198M as demand broke in H2. That build compressed operating cash flow to $81.7M even though net income was $104.5M.
FY2023: trough. Demand weakened in all major markets. Kronos cut utilisation to 72%, and unabsorbed fixed costs plus elevated feedstock and energy costs drove a gross margin of 9.9% and a net loss of $49.1M. The dividend ($0.76/share, $87.5M) was maintained, but it was funded from the balance sheet: cash fell from $328M to $195M.
FY2024: recovery plus structural change. Volumes recovered and utilisation hit 96%. The LPC buyout added 100% of Lake Charles output, and North American share rose to 17%. Reported net income of $86.2M includes the $64.5M LPC remeasurement gain and is depressed by $24.7M of discrete deferred-tax charges. The 2025 notes were refinanced at 9.50%, roughly 2.5x the prior coupon, which drove interest expense from $17M to $43M. The dividend was cut to $0.05/quarter mid-year.
FY2025: second trough, more severe. Average TiO2 prices fell 4% for the year and exited 10% below where they started. Tariff-related inventory pre-positioning raised SG&A, and management chose to defend liquidity by curtailing output to 55% in Q4. The result was ≈$111M of unabsorbed fixed cost, a segment loss of $22.2M and a net loss of $110.9M, including ≈$28M of non-cash German tax charges. Cash fell to $33M and net debt reached ≈$544M.
H1 FY2026: inflection. The Q4-2025 restructuring (226 positions), lower feedstock costs, market-share gains from competitor closures (Tronox Botlek, Venator UK) and EU anti-dumping duties drove a 16% volume gain in Q2. Q2 EBITDA was $52.9M (9.5% margin) and Q2 net income $15.2M. Selling prices rose 4% within H1 but were still 4% below H1 2025 on average. A stronger euro adds to sales but cut Q2 segment profit by ~$12M. Inventory release lifted TTM FCF to +$40M.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
TiO2 segment net sales (USD Mn; = consolidated net sales) | 1,666.5 | 1,887.1 | 1,859.4 |
TiO2 segment profit (loss) (USD Mn) | -46.8 | 141.0 | -22.2 |
Segment margin (%) | -2.8 | 7.5 | -1.2 |
YoY net sales growth (%) | -13.7 | 13.2 | -1.5 |
Contribution to total revenue (%) | 100 | 100 | 100 |
Revenue Lines
| Revenue line | FY2025 |
|---|---|
Core TiO2 pigments (USD Mn, ≈90%) | 1,673 |
Complementary businesses: ilmenite, ecochem, specialty chemicals (USD Mn, ≈10%) | 186 |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
TiO2 production volume (000 metric t) | 401 | 535 | 480 |
TiO2 sales volume (000 metric t) | — | 504 | 512 |
Average capacity utilisation (%) | 72 | 96 | 77 |
Unabsorbed fixed production cost (USD Mn) | — | 12 | 111 |
Segment Revenue
| Metric | Q1-25 | Q2-25 | Q3-25 | Q4-25 | Q1-26 | Q2-26 |
|---|---|---|---|---|---|---|
Net sales | 489.8 | 494.4 | 456.9 | 418.3 | 509.8 | 558.1 |
Segment profit (loss) | 41.6 | 10.9 | -15.3 | -59.4 | 15.1 | 41.0 |
EBITDA (company definition) | 51.2 | 22.2 | 0.6 | -57.9 | 27.7 | 52.9 |
Net income (loss) | 18.1 | -9.2 | -37.0 | -82.8 | -4.8 | 15.2 |
Capacity utilisation (%) | 93 | 81 | 80 | 55 | — | — |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (USD Mn) | 1,939.4 | 1,930.2 | 1,666.5 | 1,887.1 | 1,859.4 |
Gross profit (USD Mn, S&P std.) | 446.2 | 391.1 | 164.9 | 375.3 | 216.9 |
Operating income (USD Mn, S&P std.) | 169.0 | 132.5 | -65.6 | 137.9 | -43.7 |
EBITDA (USD Mn, company definition) | 224.3 | 202.5 | -7.2 | 252.9 | 16.1 |
Interest expense (USD Mn) | 19.6 | 16.9 | 17.1 | 42.9 | 53.0 |
Pre-tax income (USD Mn) | 153.4 | 133.9 | -72.9 | 149.6 | -97.4 |
Income tax expense (benefit) (USD Mn) | 40.5 | 29.4 | -23.8 | 63.4 | 13.5 |
Net income (USD Mn) | 112.9 | 104.5 | -49.1 | 86.2 | -110.9 |
EPS basic (USD) | 0.98 | 0.90 | -0.43 | 0.75 | -0.96 |
EPS diluted (USD) | 0.98 | 0.90 | -0.43 | 0.75 | -0.96 |
Dividends per share (USD) | 0.72 | 0.76 | 0.76 | 0.48 | 0.20 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 23.0 | 20.3 | 9.9 | 19.9 | 11.7 |
Operating margin (%) | 8.7 | 6.9 | -3.9 | 7.3 | -2.4 |
EBITDA margin (%) | 11.6 | 10.5 | -0.4 | 13.4 | 0.9 |
Net margin (%) | 5.8 | 5.4 | -2.9 | 4.6 | -6.0 |
Margin Analysis (%) (Half-Yearly)
| Metric | H1 FY2025 | H1 FY2026 |
|---|---|---|
Net sales | 984.2 | 1,067.9 |
Gross margin | 169.7 | 186.1 |
Income from operations | 45.8 | 50.2 |
Segment profit | 52.5 | 56.1 |
EBITDA | 73.4 | 80.6 |
Net income | 8.9 | 10.4 |
TiO2 sales volume (000 t) | 268 | 295 |
TiO2 production volume (000 t) | 268 | 263 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (USD Mn) | 2,013 | 1,934 | 1,838 | 1,914 | 1,817 |
Cash & equivalents (USD Mn) | 406.0 | 327.8 | 194.7 | 106.7 | 33.2 |
Short-term debt incl. current leases (USD Mn) | 5.1 | 4.9 | 3.9 | 81.8 | 4.2 |
Long-term debt incl. leases (USD Mn) | 465.6 | 441.5 | 459.5 | 446.2 | 573.1 |
Total debt incl. leases (USD Mn) | 470.7 | 446.4 | 463.4 | 528.0 | 577.3 |
Net debt (USD Mn) | 64.7 | 118.6 | 268.7 | 421.3 | 544.1 |
Shareholders' equity (USD Mn) | 870.2 | 957.2 | 808.3 | 817.0 | 751.1 |
Goodwill & intangibles (USD Mn) | 0.0 | 0.0 | 0.0 | 2.6 | 2.6 |
Working capital (USD Mn) | 969.2 | 915.5 | 746.6 | 628.7 | 625.7 |
Inventory (USD Mn) | 432.3 | 608.7 | 564.6 | 656.7 | 628.6 |
Pension & OPEB liabilities (USD Mn) | 301.9 | 139.3 | 161.3 | 127.9 | 91.2 |
Capital Instruments
| Instrument | Principal | Rate | Maturity | Notes |
|---|---|---|---|---|
KII 9.50% Senior Secured Notes | €426.174M (≈$500M at ~1.17 USD/EUR) | 9.50% fixed | March 2029 | Issued Feb 2024 (€276.174M), Jul 2024 (+€75M) and Sep 2025 (+€75M). Guaranteed by Kronos and domestic subsidiaries; first-priority security on certain assets |
Contran subordinated unsecured term loan | $53.7M (€50M) | Rate stepped from 9.54% to 11.50% (2025 per XBRL) | — | Covenants substantially similar to the notes; interest payable in cash |
Global Revolver (Wells Fargo-led ABL) | $350M facility (raised from $300M in Q2 2025) | Variable | — | Year-end 2025 drawn balance not separately verified (residual ≈$0–10M implied by total debt) |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (USD Mn) | 206.5 | 81.7 | 5.5 | 72.5 | 2.5 |
Capital expenditure (USD Mn) | 58.6 | 63.2 | 47.4 | 29.5 | 42.9 |
Free cash flow (USD Mn) | 147.9 | 18.5 | -41.9 | 43.0 | -40.4 |
Dividends paid (USD Mn) | 83.2 | 87.8 | 87.5 | 55.2 | 23.0 |
Share buybacks (USD Mn) | 0.2 | 2.3 | 2.9 | 0.0 | 0.0 |
Acquisitions, net of cash (USD Mn) | 0.0 | 0.0 | 0.0 | 156.8 | 0.0 |
Cash interest paid (USD Mn) | 18.0 | 15.7 | 15.8 | 38.2 | 47.4 |
Cash taxes paid (USD Mn) | 41.6 | 37.3 | 17.3 | 34.5 | 44.9 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%, NI / year-end equity) | 13.0 | 10.9 | -6.1 | 10.6 | -14.8 |
ROA (%, NI / year-end assets) | 5.6 | 5.4 | -2.7 | 4.5 | -6.1 |
ROIC (%, EBIT×0.75 / (equity + net debt)) | 13.6 | 9.3 | -4.6 | 8.4 | -2.5 |
Current ratio (x) | 4.36 | 3.80 | 3.01 | 2.32 | 2.70 |
Debt / equity (x) | 0.54 | 0.47 | 0.57 | 0.65 | 0.77 |
Net debt / EBITDA (x) | 0.29 | 0.59 | -37.3 | 1.67 | 33.8 |
Interest coverage (x, EBIT / interest) | 8.6 | 7.8 | -3.8 | 3.2 | -0.8 |
Asset turnover (x) | 0.96 | 1.00 | 0.91 | 0.99 | 1.02 |
DSO (days) | 64 | 41 | 63 | 51 | 52 |
DIO (days) | 106 | 144 | 137 | 159 | 140 |
DPO (days) | 39 | 46 | 58 | 56 | 50 |
Cash conversion cycle (days) | 131 | 139 | 142 | 154 | 142 |
Revenue by Region and Revenue by Region (%)
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
United States revenue (USD Mn, derived) | 566.6 | 641.6 | 669.4 |
Non-US revenue (USD Mn, derived) | 1,099.9 | 1,245.5 | 1,190.0 |
US share of revenue (%) | 34 | 34 | 36 |
Non-US share of revenue (%) | 66 | 66 | 64 |
Geographic Revenue
| Region | FY2024 YoY (%) | FY2025 YoY (%) |
|---|---|---|
United States | 13.2 | 4.3 |
Non-US | 13.2 | -4.5 |
Revenue by Region (%)
| Region | FY2024 | FY2025 |
|---|---|---|
Europe (%) | 44 | 45 |
North America (%) | — | 40 |
Asia Pacific (%) | — | 8 |
Rest of World / export (%) | — | 7 |
Markets
| Market | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Europe share of TiO2 volume (%) | 12 | 14 | 15 |
North America share of TiO2 volume (%) | 16 | 17 | 19 |
Global share of TiO2 volume (%) | — | — | 7 |
Data Point Details
| Data point | Value | Source |
|---|---|---|
Close 31 Aug 2026 | $8.82 | S&P Global via StockAnalysis |
Close 11 Sep 2026 | $8.20 | S&P Global via StockAnalysis |
Intraday 17 Sep 2026 | $8.23 | S&P Global via StockAnalysis |
Earlier 52-week range (as quoted on a third-party page, spring 2026) | $4.08–$7.89 | Third-party data page; not primary |
Capital Markets
| Series | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
Kronos TSR index | 100 | 106 | 70 | 81 | 83 | 39 |
S&P 500 index | 100 | 129 | 105 | 133 | 166 | 196 |
Peer group (Chemours, Tronox) index | 100 | 149 | 119 | 127 | 78 | 48 |
Valuation Multiples
| Multiple | Kronos | Basis |
|---|---|---|
Market capitalisation | ≈ $943M | 115.05M shares × $8.20 |
Enterprise value | ≈ $1,505M |
|
P/E (TTM) | n/m | TTM net loss −$109.4M |
EV/EBITDA (TTM) | ≈ 65x | TTM EBITDA ≈ $23.3M (trough-distorted) |
EV/EBITDA (Q2-26 annualised) | ≈ 7.1x | Q2 EBITDA $52.9M × 4 |
EV/Sales (TTM) | ≈ 0.77x | TTM revenue $1,943M |
P/B | ≈ 1.26x | Equity $751M (Jun 2026) |
Dividend yield | ≈ 2.4% | $0.20 annualised |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends declared per share (USD) | 0.72 | 0.76 | 0.76 | 0.48 | 0.20 |
Capital Instruments (Annual)
| Instrument | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
9.50% Senior Secured Notes (EUR Mn) | 0 | 0 | 0 | 426.2 |
Contran subordinated term loan (USD Mn) | 0 | 0 | 0 | 53.7 |
Analyst Conclusions
Management guidance (Q2-2026 release, 5 Aug 2026; no numeric guidance).
-
Positive momentum entering H2-2026 from operational, commercial and cost initiatives.
-
Energy and related costs remain elevated, with pricing actions and cost discipline expected to offset them.
-
Focus on sustainable earnings improvement and stronger cash flow.
-
2026 capex for environmental compliance and efficiency ≈$30M; R&D ≈$13M.
-
Feedstock purchases expected at $375–450M.
Sell-side price targets rose to $8–9 in August–September 2026, implying expectations of continued recovery in EBITDA and EPS in H2-2026 and 2027.
Bull case.
-
Supply-side reset in Kronos's core markets. Roughly 700 kt+ of Western and Chinese capacity has been closed or idled since 2023 (Chemours Taiwan, Tronox Botlek, Venator UK, Tronox China). Combined with anti-dumping duties, this has already produced a 16% volume gain in Q2-2026 and record European share (15%).
-
Operating leverage on a lower cost base. Q4-2025 carried $54M of unabsorbed costs at 55% utilisation, and Q2-2026 EBITDA reached $52.9M. If utilisation returns to ~90% with modest pricing gains, annual EBITDA could approach or exceed the FY2024 underlying level (≈$190M ex-gain).
-
Pricing inflection plus cash release. Prices rose 4% within H1-2026 after a 10% fall during 2025. Inventory liquidation turned TTM free cash flow positive (+$40M), and there are no debt maturities before 2029.
Bear case.
-
Balance-sheet fragility. Net debt of ≈$560M sits against trough EBITDA, with $26.6M of cash. Annual interest of ~$57M on 9.50% notes and an 11.50% Contran loan consumes much of normalised free cash flow and constrains dividends and capex.
-
China's chloride expansion. LB Group's ~200 kt chloride build-out and lower-cost Chinese supply could cap price recovery outside protected markets. Exports already declined in 2025.
-
Macro and FX headwinds. Coatings (59% of volume) depend on weak housing markets, European energy costs remain elevated, and euro strength cut segment profit by $18M in H1-2026. Recovery could stall if destocking returns.
Key catalysts and monitorables (next 12 months).
Concluding analyst verdict.
Kronos Worldwide enters Q4 2026 as a recovering, high-beta, controlled small-cap. Its fundamentals have clearly passed the trough, but its balance sheet has not yet caught up.
2025 was among the worst years in the company's modern history. Average prices exited the year 10% lower, utilisation fell to 55% in Q4, unabsorbed costs reached $111M and the net loss was $110.9M. Liquidity was squeezed to a $33M year-end cash balance.
Management's response was decisive. It curtailed output to cut inventory, removed about 10% of the workforce, terminated the US pension plan and pushed refinancing out to 2029. Under new CEO Brian Christian, the first-half 2026 data show these actions working. Volumes rose 16% in Q2, EBITDA recovered to $52.9M, the company returned to a quarterly profit and inventory release turned trailing free cash flow positive.
The strategic backdrop is more favourable than at any time since 2021. Western competitors have exited capacity, Venator's UK assets are idle and anti-dumping regimes protect Kronos's European and Latin American markets, where it now holds record share. Lake Charles adds a tariff-resilient US base.
Offsetting this, leverage is structurally high. There is roughly $560M of net debt at a 9.50% coupon, and on trailing figures the company is still loss-making. Earnings sensitivity to price, energy and the euro remains extreme. Chinese chloride expansion also caps the upside to pricing over the medium term.
At ~$8.20, the shares trade at about 0.8x trailing EV/Sales and about 1.3x book, and around 7x annualised Q2 EBITDA. That valuation already discounts a meaningful part of the recovery. The equity is best viewed as a leveraged call on continued TiO2 supply discipline and pricing through 2027, with downside cushioned somewhat by Contran's demonstrated willingness to support liquidity.
Verdict: improving fundamentals, constructive industry structure, but balance-sheet and cyclical risk keep this a speculative, catalyst-dependent position. Monitor Q3-2026 pricing and cash generation before underwriting a sustained re-rating.
Primary sources referenced
-
Kronos Worldwide FY2025 Form 10-K (filed 9 Mar 2026) — SEC EDGAR, CIK 0001257640
-
Kronos Q4/FY2025 earnings release (8-K Ex. 99.1, 9 Mar 2026)
-
Kronos Q1-2026 earnings release (6 May 2026); Q2-2026 earnings release and 10-Q (5 Aug 2026)
-
Kronos 8-Ks: 6 Aug 2025 (CFO change), 20 Feb 2026 (CEO change), 13 May 2026 (AGM results)
-
Kronos 2026 DEF 14A (24 Mar 2026), table of contents and nominee list
-
Valhi, Inc. 10-K/10-Q filings (2024–2025) for debt detail and corporate history; NL Industries FY2025 10-K summaries
-
Kronos IR press releases on €75M add-on notes offerings (2024, 2025)
-
Tronox FY2025 results release (Feb 2026); Chemours Q4/FY2025 results release
-
S&P Global Market Intelligence standardised financials and dividend history via StockAnalysis.com (updated Aug–Sep 2026)
-
European Coatings (Mar 2026) and Zacks / 247WallSt earnings summaries for consensus comparisons
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | In role since | Prior roles / background | Age |
|---|---|---|---|---|
Brian W. Christian | President & CEO; Director | CEO and director since 27 Feb 2026; President since May 2025 | COO 2023–Feb 2026; EVP 2016–May 2025; Chief Strategy Officer 2021–2023; VP Strategic Business Development 2011–2016; Manager, Strategic & Financial Planning 2009–2011; Contran-group strategic/financial planning roles since 2006 | ~46–47 (GlobalData listed 46 c.2025) |
Bradley E. Troutman | SVP & Chief Financial Officer | 8 Aug 2025 | CFO, Pegasus Logistics Group (2024–Jul 2025); CFO, Atlantic Aviation (2019–2022) | 51 at appointment (8-K, Aug 2025) |
Bryan S. Bell | Principal Accounting Officer | Aug 2025 | Contran-group accounting roles | — |
Bryan A. Hanley | SVP & Treasurer (IR contact) | — | Contran-group treasury | — |
John A. Sunny | EVP & Chief Information Officer | CIO since 2015; EVP later | Leads cybersecurity programme | ~62 (GlobalData) |
(Gruber) | EVP, Chief Manufacturing & Technology Officer | 2022 | Kronos manufacturing and technology leadership | ~57 (GlobalData; full first name not captured) |
“—” = not publicly disclosed.
Board of Directors
| Director | Role / affiliation | Independence |
|---|---|---|
Loretta J. Feehan | Chair of the Board; long-time Contran-group director and executive | Non-independent (affiliated) |
Brian W. Christian | President & CEO | Non-independent |
Michael S. Simmons | Simmons family member / Contran group | Non-independent |
John E. Harper | Independent director | Independent |
Kevin B. Kramer | Independent director | Independent (per proxy definition) |
Meredith W. Mendes | Independent director | Independent |
Cecil H. Moore, Jr. | Independent director (audit/finance background) | Independent |
Dr. R. Gerald Turner | Independent director (President Emeritus, Southern Methodist University) | Independent |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
Valhi, Inc. (direct) | ~50% | FY2025 10-K |
NL Industries, Inc. (wholly-owned subsidiary) | ~31% | FY2025 10-K |
Combined Contran-group control | ~81% (≈93.3M shares) | Derived |
Public / non-affiliate float | ~19% (≈21.7M shares) | FY2025 10-K cover |
Holders of record | ~1,400 (27 Feb 2026) | FY2025 10-K |
Competitive Landscape
Peer Comparison
| Producer | % of global capacity |
|---|---|
LB Group (Lomon Billions), China | 14 |
Chemours, USA | 11 |
Tronox, UK/USA | 11 |
Kronos | 6 |
Others | 58 |
Key Competitors
| # | Competitor | HQ | Positioning vs. Kronos |
|---|---|---|---|
| 1 | The Chemours Company (Titanium Technologies segment; Ti-Pure™) | USA | ~50% of North American capacity; Kronos's principal North American rival; larger, chloride-only, global |
| 2 | Tronox Holdings plc | UK/USA | Vertically integrated into mineral sands (an advantage when feedstock prices rise); closed Botlek (90 kt) in 2025 and is closing a 46 kt China sulfate plant (2026) |
| 3 | LB Group Co., Ltd. | China | World's largest; adding ~200 kt of chloride capacity; low-cost, price-setting swing supplier |
| 4 | Venator Materials (UK parent in insolvency, 2025) | UK | ~400 kt idled; former LPC partner; a potential re-entry or acquisition risk |
| 5 | CNNC Hua Yuan Titanium Dioxide | China | Large sulfate producer; export competitor |
| 6 | Pangang Group Vanadium Titanium & Resources | China | Integrated Chinese producer; chloride expansion |
| 7 | Shandong Doguide (Dongjia) Group | China | Sulfate and chloride exporter |
| 8 | Ishihara Sangyo Kaisha (ISK) | Japan | Specialty and Asia-focused |
| 9 | Precheza a.s. (Agrofert) | Czech Republic | European sulfate competitor |
| 10 | Grupa Azoty Police | Poland | European sulfate competitor |
| 11 | Tayca Corporation | Japan | Specialty / ultrafine TiO2 |
Peer Comparison FY2025
| Metric | Kronos | Tronox | Chemours (TT segment) | LB Group |
|---|---|---|---|---|
Revenue | $1,859M (total) | $2,898M (total, incl. zircon & pig iron) | — | — |
Revenue growth FY2025 | −1.5% | −6% | — | — |
EBITDA / margin | $16.1M / 0.9% (company definition, unadjusted) | Adjusted EBITDA $336M / 11.6% | Chemours total adj. | — |
Net result | −$110.9M | −$470M (incl. $233M restructuring, net) | Chemours total −$386M | — |
R&D intensity | 0.9% | — | — | — |
Feedstock integration | Partial (sulfate ilmenite only) | Full (mineral sands) | — | Substantial (Chinese ore) |
Process mix | 83% chloride | Predominantly chloride | 100% chloride | Mixed; chloride expanding |
Recent Developments
Q3 2026 results are expected in early November 2026 and had not been released as of the dossier date.
